Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-090468

Chief Executive Officer sold 2,788 shares at $9.25 ($25,789)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2020-08-03 Sale −2,788 $9.25 $25,789 3,064 D: show line 1 in the form
Open-market sales · 2,788 sh · avg $9.25 · $25,789
Loading xslF345X03/a4.xml…